Zelapar Drug Information

Because many of the symptoms of Parkinson's disease are thought to be caused by a dopamine deficiency, Zelapar® (orally disintegrating selegiline) is often prescribed to increase the amount of dopamine in the brain. Zelapar is approved for use in combination with carbidopa-levodopa medications such as Sinemet®, Sinemet CR®, or Parcopa®. It is taken once a day and is particularly useful for people who have trouble swallowing tablets, as it dissolves rapidly on the tongue.
 
If you have certain other medical conditions, such as liver disease, your healthcare provider needs to know this information when prescribing Zelapar. This drug may not be appropriate in these situations, and discussing these and other issues with your healthcare provider will help ensure the safety and effectiveness of your treatment plan.
 
(For more information, click Zelapar. This article gives a comprehensive overview of this drug, including a discussion on how it works, generic availability, side effects, and more.)
 

Zelapar Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.